LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 136 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.11 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $511,935 | -54.7% | 469,666 | -4.8% | 0.00% | -60.0% |
| Q2 2023 | $1,129,295 | +192.3% | 493,142 | +210.2% | 0.01% | +150.0% |
| Q1 2023 | $386,370 | +72.9% | 159,000 | +35.9% | 0.00% | +100.0% |
| Q4 2022 | $223,470 | -13.7% | 117,000 | +54.6% | 0.00% | -33.3% |
| Q4 2020 | $259,000 | +33.5% | 75,700 | +379.7% | 0.00% | -83.3% |
| Q3 2017 | $194,000 | +35.7% | 15,781 | +57.8% | 0.02% | +28.6% |
| Q1 2017 | $143,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |